Study to Evaluate the Efficacy and Safety of XC243 in Patients With Exacerbation of Chronic Cystitis
Clinical trial NCT06391164 · UNKNOWN
Trial details
- NCT number
- NCT06391164
- Sponsor
- PHARMENTERPRISES LLC
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2025-12-01
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.